Chad Robins is the founder of Adaptive Biotechnologies. Adaptive Biotechnologies has raised $700M in total funding. Latest round: IPO. Based in Seattle, USA.
Chad Robins is the CEO and co-founder of Adaptive Biotechnologies, a commercial-stage biotechnology company that translates the genetics of the adaptive immune system into clinical products. He led the company through a $300 million IPO in June 2019 and over $400 million in prior fundraising.
Full founder directory · Investor directory · Company funding database · Fundraising library